Bradley partner Tripp Haston will serve on a panel analyzing changes in the state of law regarding ex parte communications with prescribing HCPs, interaction with third party witnesses and other non-pharma/device defendants. The conference is sponsored by the ABA’s Section of Litigation Pharmaceutical, Medical Device and Biotech Subcommittee of the Product Liability Committee.
For more information, visit the American Bar Association website .
Esther Berezofsky, Williams Cuker Berezofsky
Mark Cheffo, Quinn Emanual Urquhart & Sullivan, LLP
Beth Rose, Sills Cummis & Gross